We're hosting events nationwide (and virtually) to tackle the biggest questions in health and medicine.
"STAT Summits connects you with today's innovators and tomorrow's thought leaders"
Jason Lippman Solutions, LLC
Browse our upcoming events — or see the full list of industry events and other STAT events we have scheduled.
2021 STAT Breakthrough Science Summit
Come here for the cutting edge. Technologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit will take you inside these innovations, examining how they're being developed, adopted, and paid for.
STAT+ Conversations: A conversation about the revitalization of the antibiotic drug pipeline
STAT's Pharmalot Columnist, Ed Silverman, is joined by Dr. John H. Rex, editor-in-chief of AMR Solutions and chief medical officer of F2G Ltd. to discuss a recent report on the future of the antibiotic drug pipeline.
TYPES OF EVENTS
We have something for everyone. Get in touch with us to learn how to sponsor an upcoming event.
When circumstances permit, we host multiple in-person events per year for STAT readers and subscribers around the country.View Upcoming Events
Join us for our online events featuring industry experts and deep-dive webinars on industry trends.View Upcoming Virtual Events
Ranging from half-day to multi-day programming, and bringing the biggest names in biopharma, policy, and technology to the stage.View Upcoming Summit
Take a peek at past events, and access session recordings if you weren’t able to join us live.
2021 STAT Health Tech Summit
Biology and technology are converging to change medicine. The 2021 STAT Health Tech Summit brought together experts working at the intersection of tech and health care — at both Silicon Valley giants and upstarts just emerging from stealth — as they continue to design the future of health.
Biotech: Where are we now?
STAT's Kate Sheridan is joined by two of biotech's biggest names, Doug Cole, managing partner at Flagship Pioneering, and Helen Torley, president and chief executive officer of Halozyme Therapeutics, to take a look at how Covid-19 has changed the industry.
The ASCO Recap, Live!
After the biggest meeting in cancer research, STAT's Adam Feuerstein sits down with cancer’s biggest decision-maker: the director of the Food and Drug Administration’s Oncology Center of Excellence. They discuss his thoughts on the latest trends in cancer drug development.
The 2020 STAT Summit
The coronavirus pandemic has reset our expectations of what is possible. New medicines and vaccines are being developed at a previously unimaginable pace and telemedicine has replaced the doctor’s office. The 2020 STAT Summit brought together some of the greatest minds in science and medicine to discuss the big question on everyone’s mind: What’s next?
Receive a monthly newsletter about upcoming events and promotions from STAT and our partners.